Prevalence of Chronic Obstructive Pulmonary Disease in HIV-patient Population
The management of HIV is mainly represented by its commorbidities (cardio-vascular disease,
nephrologic, neurologic, osteo-articular disease, chronic hepatitis and cancer no linked to
immunodepression). COPD prevalence has never been studied in HIV population. In consequence,
there is no guideline about the screening, treatment or follow-up of COPD in HIV patients.
However this population seems particularly at risk to develop COPD because of high tobacco
consumption and accelerate ageing. Thus, we need an epidemiologic study to understand the
prevalence of COPD in HIV population in order to organize a specific screening and
follow-up. This is supported by an improvement of COPD if early managed. On top of that,
COPD screening will increase awareness of HIV patients on the problematic of tobacco
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Evaluation of Chronic obstructive pulmonary disease prevalence in a large population of HIV patients
An auto-questionnaire will be given to each patient included in the study (concern respiratory symptoms, tobacco consummation, illicit drug use, various respiratory exposition and lifestyle). Each patient will release a rapid evaluation of respiratory capacity with COPD-6. Patients screened with abnormal respiratory symptoms on auto-questionnaire, or with a risk of COPD ranked from high to moderate by COPD-6 test will benefit of a conventional spirometry.
one time each patient (one hour)
Karine RISSO, MD
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)